| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 09/17/2003 | CN1443067A Analgesic and anti-inflammatory compositions containing cox-2 inhibitors |
| 09/17/2003 | CN1443065A Pharmaceutical composition improved in peroral absorbability |
| 09/17/2003 | CN1442178A Rheumatoid disease health recovery admixture |
| 09/17/2003 | CN1442157A Medicine for treating rheumatic and rheumatoid disease and its preparation method |
| 09/17/2003 | CN1442139A Medicinal composition for treating inflammation |
| 09/17/2003 | CN1121374C Novel trienoic retinoid compounds and method |
| 09/17/2003 | CN1121236C Medicine for curing rheumatoid arthritis and preparing method |
| 09/17/2003 | CN1121234C Antiphlogistic cough relieving medicine |
| 09/16/2003 | US6620851 Methods for the treatment of neuropathic pain and other disorders using R(−)-ketoprofen |
| 09/16/2003 | US6620840 Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 09/16/2003 | US6620832 Substituted ureas |
| 09/16/2003 | US6620831 Indazoles substituted with 1,1-dioxoisothiazolidine useful as inhibitors of cell proliferation |
| 09/16/2003 | US6620823 Antiinflammatory agents; rheumatic disorders |
| 09/16/2003 | US6620820 Inhibitors of bone reabsorption and antagonists of vitronectin receptors |
| 09/16/2003 | US6620817 Antiinflammatory, antiarthritic agents; autoimmune and rheumatic diseases |
| 09/16/2003 | US6620811 Isonicotin- and nicotinamide derivatives of benzothiazoles |
| 09/16/2003 | US6620782 compounds having Formula I are potent inhibitors of caspases and apoptotic cell death. Therefore, the inhibitors of this invention can retard or block cell death in a variety of clinical conditions in which the loss of cells, tissues or |
| 09/16/2003 | US6620435 Compositions for topical application of therapeutic agents |
| 09/16/2003 | US6620433 Dispersible and soluble galenic paracetamol formulation, method for its preparation and its applications |
| 09/16/2003 | CA2249009C Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors |
| 09/16/2003 | CA2054590C Novel cyclosporins |
| 09/12/2003 | WO2003075015A2 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 09/12/2003 | WO2003075003A1 Therapeutic properties of oils |
| 09/12/2003 | WO2003074711A1 Expression cassette for persistence of expression of a gene of interest in muscle cells |
| 09/12/2003 | WO2003074681A1 Recombinant spores |
| 09/12/2003 | WO2003074654A2 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina) |
| 09/12/2003 | WO2003074560A2 Critical hypoxia-inducible factor-1alpha residues, products and methods related thereto |
| 09/12/2003 | WO2003074520A1 Thiadiazolylpiperazine derivatives useful for treating or preventing pain |
| 09/12/2003 | WO2003074516A1 Phthalimide carboxylic acid derivatives |
| 09/12/2003 | WO2003074515A1 Diamino-pyrimidines and their use as angiogenesis inhibitors |
| 09/12/2003 | WO2003074512A1 Isoquinoline derivatives |
| 09/12/2003 | WO2003074495A1 Hppars activators |
| 09/12/2003 | WO2003074489A1 Cyclic n-substituted alpha iminocarboxylic acids for selectively inhibiting collagenase |
| 09/12/2003 | WO2003074483A1 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient |
| 09/12/2003 | WO2003074479A1 Semicarbazide derivatives and their use as antithrombotics |
| 09/12/2003 | WO2003074073A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
| 09/12/2003 | WO2003074065A1 Identification of free-b-ring flavonoids as potent cox-2 inhibitors |
| 09/12/2003 | WO2003074062A2 Isolation, purification and structural identification of a bioactive component of a water soluble extract of a botanical species for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals |
| 09/12/2003 | WO2003074060A2 Dna demethylase antisense and chemotherapy combination |
| 09/12/2003 | WO2003074048A1 Method of treating osteoarthritis |
| 09/12/2003 | WO2003074013A1 Use of sugar esters in cosmetic and/or pharmaceutical preparations |
| 09/12/2003 | WO2003074008A2 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 09/12/2003 | WO2003073986A2 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 09/12/2003 | WO2003073983A2 Methods and compositions in treating pain using diacylglycerol kinase epsilon |
| 09/12/2003 | WO2003073982A2 Anti-interleukin-1 beta analogs |
| 09/12/2003 | WO2003051828A3 (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses |
| 09/12/2003 | WO2003051333B1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents |
| 09/12/2003 | WO2003047524A3 Methods and compositions for modulating the immune system and uses thereof |
| 09/12/2003 | WO2003045942A3 Chemokine receptor antagonists and methods of use thereof |
| 09/12/2003 | WO2003037268A3 Hepta-, octa- and nonapeptides having antiangiogenic activity |
| 09/12/2003 | WO2003034995A3 Integrin targeting compounds |
| 09/12/2003 | WO2003007794A3 Invasion complex and methods of targeting |
| 09/12/2003 | WO2002080979A3 Conjugate of hydroxyalkyl starch and an active agent |
| 09/12/2003 | WO2002072830A3 Proteins associated with cell growth, differentiation, and death |
| 09/12/2003 | WO2002058695A9 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 09/12/2003 | WO2002040486A3 METHODS OF TREATING p38 KINASE-ASSOCIATED CONDITIONS AND PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS |
| 09/12/2003 | WO2002028424A9 Kyberdrug as autovaccines with immune-regulating effects |
| 09/12/2003 | WO2002009683A3 Aldosterone blocker therapy to prevent or treat inflammation-related disorders |
| 09/12/2003 | CA2481307A1 Phthalimide carboxylic acid derivatives |
| 09/12/2003 | CA2478618A1 Isoquinoline derivatives |
| 09/12/2003 | CA2478528A1 Semicarbazide derivatives and the use thereof as antithrombotics |
| 09/12/2003 | CA2478124A1 Dna demethylase antisense and chemotherapy combination |
| 09/12/2003 | CA2478042A1 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 09/12/2003 | CA2477874A1 Expression cassette for persistence of expression of a gene of interest in muscle cells |
| 09/12/2003 | CA2477785A1 Isolation, purification and structural identification of a bioactive component of a water soluble extract of a botanical species for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals |
| 09/12/2003 | CA2477738A1 Therapeutic properties of oils |
| 09/12/2003 | CA2477715A1 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient |
| 09/12/2003 | CA2477662A1 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
| 09/12/2003 | CA2477505A1 Diamino-pyrimidines and their use as angiogenesis inhibitors |
| 09/12/2003 | CA2477449A1 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 09/12/2003 | CA2477423A1 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 09/12/2003 | CA2477391A1 Method of treating osteoarthritis |
| 09/12/2003 | CA2455447A1 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina) |
| 09/11/2003 | WO2003074500A2 N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors |
| 09/11/2003 | WO2003074054A1 Ophthalmic composition comprising ascomycin |
| 09/11/2003 | US20030171585 Anti-inflammatory compounds |
| 09/11/2003 | US20030171584 6-Substituted pyrido-pyrimidines |
| 09/11/2003 | US20030171579 N-benzyl-N'-phenylurea derivatives; inhibitors of the coagulation factors Xa and VIIa |
| 09/11/2003 | US20030171568 Diagnosing tumor or cancer in a mammal, and inflammatory diseases or disorders; inflammatory bowel disease, colon cancer; immunoassay, immunotherapy |
| 09/11/2003 | US20030171556 Diagnosis and therapeutic treatment of Alzheimer's Disease; drug screening |
| 09/11/2003 | US20030171547 Adipocyte-specific protein homologs |
| 09/11/2003 | US20030171429 Anti-inflammatory and psoriasis treatment and protein kinase inhibition by hydroxyltilbenes and novel stilbene derivatives and analogues |
| 09/11/2003 | US20030171413 Rheumatic diseases; antiarthritic agents; asthma |
| 09/11/2003 | US20030171404 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 09/11/2003 | US20030171400 Rheumatic diseases; osteoporosis; multiple sclerosis; autoimmune disease; joint replacements |
| 09/11/2003 | US20030171392 Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof |
| 09/11/2003 | US20030171389 Anticancer agents; bone disorders; antiarthritic agents |
| 09/11/2003 | US20030171380 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 09/11/2003 | US20030171365 Inhibitors of the interleukin-1beta conversion enzyme; useful in treatment of inflammatory, auto-immune and neurodegenerative diseases |
| 09/11/2003 | US20030171361 Treatment of impotence, sexual dysfunction in female, stable, unstable and variant angina, hypertension, pulmonary hypertension, congestive heart failure, atherosclerosis |
| 09/11/2003 | US20030171359 Suitable for treatment of illnesses characterised by excessive or abnormal cell proliferation; viral, bacterial, fungal and/or parasitic infections, skin diseases, bone diseases, cardiovascular diseases |
| 09/11/2003 | US20030171337 Useful in the treatment and prophylaxis of inflammatory conditions or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammalian animal including human and primate, non-mammalian animal and |
| 09/11/2003 | US20030171309 Pharmaceutically active pyrrolidine derivatives as bax inhibitors |
| 09/11/2003 | US20030171304 Pyridine-2-yl-aminoalkyl carbonyl glycyl-$g(b)-alanine and derivatives thereof |
| 09/11/2003 | US20030171300 Treating different types and symptoms of acute and chronic pain, especially non neuropathic inflammatory pain in mammals. The pain to be treated may be e.g. chronic inflammatory pain, rheumatoid arthritis pain and/or secondary |
| 09/11/2003 | US20030171280 Compositions and methods for modulation of immune responses |
| 09/11/2003 | US20030171278 Novel compounds which bind to the human erbB2 gene product (ErbB2, also known as HER2, or c-ErbB-2). In particular aspects, the invention provides for the treatment of disorders characterized by the overexpression of ErbB2 utilizing the |
| 09/11/2003 | US20030171267 Albumin fusion proteins |
| 09/11/2003 | US20030171264 Microemulsion preconcentrate; reduced toxicity but high bioavailability; contain cyclosporin A analog ISATx247 (Voclosporin), tocopheryl polyethylene glycol 1000 succinate (Vitamin E TPGS), medium chain triglyceride (MCT) oil, a Tween" emulsifier, and ethanol |
| 09/11/2003 | US20030170859 Gene expression inhibition; for treatment of inflammatory, neurological, cardiovascular, and neoplastic tisssue growth disorders |